These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33518287)

  • 1. 14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.
    Pair FS; Yacoubian TA
    Trends Pharmacol Sci; 2021 Apr; 42(4):226-238. PubMed ID: 33518287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
    Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
    Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
    Lin D; Zeng Y; Tang D; Cai Y
    Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention.
    Huang Y; Todd N; Thathiah A
    Curr Opin Pharmacol; 2017 Feb; 32():96-110. PubMed ID: 28288370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of NAD-interacting proteins highlights the extent of NAD regulatory roles in the cell and its potential as a therapeutic target.
    Duarte-Pereira S; Matos S; Oliveira JL; Silva RM
    J Integr Bioinform; 2023 Jun; 20(2):. PubMed ID: 36880517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TRPs in neurodegenerative disorders.
    Takada Y; Numata T; Mori Y
    Curr Top Med Chem; 2013; 13(3):322-34. PubMed ID: 23432063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
    Hijioka M; Inden M; Yanagisawa D; Kitamura Y
    Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.
    Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A
    Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.
    Wilkaniec A; Czapski GA; Adamczyk A
    J Neurochem; 2016 Jan; 136(2):222-33. PubMed ID: 26376455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting erythropoietin for chronic neurodegenerative diseases.
    Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K
    Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges.
    Serafino A; Giovannini D; Rossi S; Cozzolino M
    Expert Opin Drug Discov; 2020 Jul; 15(7):803-822. PubMed ID: 32281421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development.
    Grabska-Kobyłecka I; Szpakowski P; Król A; Książek-Winiarek D; Kobyłecki A; Głąbiński A; Nowak D
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 proteins as potential therapeutic targets.
    Zhao J; Meyerkord CL; Du Y; Khuri FR; Fu H
    Semin Cell Dev Biol; 2011 Sep; 22(7):705-12. PubMed ID: 21983031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Patent Advances for Neurodegenerative Disorders and its Treatment.
    Kumar B; Sharma D
    Recent Pat Drug Deliv Formul; 2017; 11(3):158-172. PubMed ID: 29032765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese Medicine: A Hope for Neurodegenerative Diseases?
    Law BYK; Wu AG; Wang MJ; Zhu YZ
    J Alzheimers Dis; 2017; 60(s1):S151-S160. PubMed ID: 28671133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3: A Case Study in PPI Modulation.
    Ballone A; Centorrino F; Ottmann C
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Studies in Drug Research Against Neurodegenerative Diseases.
    Makhouri FR; Ghasemi JB
    Curr Neuropharmacol; 2018; 16(6):664-725. PubMed ID: 28831921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer and its applications in neurodegenerative diseases.
    Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
    Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of
    Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
    Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.